Skip to main content
FHTX logo
FHTX
(NASDAQ)
Foghorn Therapeutics Inc.
$5.07-- (--)
Loading... - Market loading

Foghorn Therapeutics (FHTX) Stock Price & Financial Analysis

Foghorn Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.99 - $5.16
52-Week High$6.95
52-Week Low$3.27
Open$5.12
Volume136.49K
Average Volume (3M)341.24K
Market Cap352.57M
Shares Outstanding69.54M
Price to Sales (P/S)12.49
Price to Book (P/B)-4.61
EV/EBITDA-3.90
Revenue (TTM)28.22M
Net Income (TTM)-75.32M
Free Cash Flow (TTM)-87.42M
EPS (TTM)$-1.17
Profit Margin-266.88%
Operating Margin-286.16%
50-Day MA$4.50
200-Day MA$4.86
52-Week Change-21.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Foghorn Therapeutics

What is the current stock price for FHTX?

As of the latest trading session, FHTX stock trades at $5.07. The 52-week range is $3.27–$6.95, with a day range of $4.99–$5.16.

What is the P/E ratio for FHTX?

The P/E ratio (Price-to-Earnings) for FHTX is shown in the Key Statistics section. This valuation metric helps compare Foghorn Therapeutics Inc. to industry peers.

Does FHTX pay dividends?

Foghorn Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FHTX?

Based on 5 analysts, the consensus for FHTX is Buy.

What is the market cap of FHTX?

Foghorn Therapeutics's market capitalization is $352.6M, classifying it as a small-cap company. Foghorn Therapeutics operates in the Healthcare sector within the Biotechnology industry.